Jennifer Alberts, MD
Dermatology · Grand Island, NENPI 1982664405
Payments from drug & device makers
Across 609 payments — averaging $16.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Novartis$775
- Sun Pharmaceutical Industries Inc.$743
- Johnson & Johnson$730
- Lilly USA, LLC$716
- Regeneron Healthcare Solutions, Inc.$485
- plus $3K from 25 others
What the payments were for
- Food & beverage$9,45195%
- Education$4785%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 204 | $3,079 |
| Novartis | 49 | $775 |
| Sun Pharmaceutical Industries Inc. | 41 | $743 |
| Johnson & Johnson | 36 | $730 |
| Lilly USA, LLC | 49 | $716 |
| Regeneron Healthcare Solutions, Inc. | 18 | $485 |
| UCB, Inc. | 27 | $451 |
| E.r. Squibb & Sons, L.L.C. | 36 | $394 |
| Amgen | 24 | $384 |
| Sanofi | 19 | $344 |
| Incyte Corporation | 19 | $296 |
| Pfizer | 16 | $292 |
| Galderma Laboratories, L.p. | 12 | $186 |
| LEO Pharma Inc. | 6 | $124 |
| Dermavant Sciences, Inc. | 6 | $98 |
| VYNE Pharmaceuticals Inc. | 6 | $95 |
| Boehringer Ingelheim | 5 | $85 |
| Kerecis Limited | 2 | $78 |
| Genentech USA, Inc. | 5 | $77 |
| Arcutis Biotherapeutics, Inc. | 5 | $75 |
| Convatec Inc. | 3 | $68 |
| Bristol Myers Squibb | 5 | $65 |
| Sandoz | 3 | $62 |
| Smith+Nephew | 2 | $55 |
| DUSA Pharmaceuticals, Inc. | 3 | $40 |
| Strata Skin Sciences, Inc. | 2 | $32 |
| Misonix Inc | 1 | $27 |
| Dermira, Inc. | 1 | $23 |
| Almirall LLC | 1 | $19 |
| Organon | 2 | $16 |
| Fresenius Kabi USA, LLC | 1 | $16 |
How this compares
$9,929 in reported general payments places this provider in the 80th percentile of 68 dermatology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 22 | $96,024 |
| Humira(Cf) PenAdalimumab | 13 | $91,820 |
| Fluorouracil | 51 | $4,951 |
| Ketoconazole | 128 | $3,284 |
| Metronidazole | 42 | $2,293 |
| Mometasone Furoate | 82 | $1,858 |
| Triamcinolone Acetonide | 116 | $1,056 |
| Mupirocin | 131 | $1,030 |
| Clobetasol Propionate | 21 | $829 |
| Clindamycin Phosphate | 21 | $693 |
| Gentamicin Sulfate | 12 | $540 |
| Imiquimod | 13 | $333 |
| Cephalexin | 73 | $228 |
| Doxycycline Hyclate | 22 | $185 |
| Hydrocortisone | 32 | $129 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Grand Island
- Susan CoreyGrand Island$9K
- Joel SchlessingerOmaha$5.5M
- Rex LargenLincoln$725K
- Mathew DaveyOmaha$389K
- Erin BarrettOmaha$144K
- Elizabeth SuttonLincoln$122K
- Rachel PersonOmaha$98K
- Sarah LonowskiOmaha$89K
- James ShehanOmaha$51K
- Casey BowenLincoln$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.